Arrowhead Pharmaceuticals
ARWR
#1766
Rank
A$17.26 B
Marketcap
A$122.58
Share price
-1.36%
Change (1 day)
395.18%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : A$2.39 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's total liabilities are A$2.39 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Arrowhead Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-09-30A$1.33 B-2.76%
2024-09-30A$1.37 B84.33%
2023-09-30A$0.74 B74.96%
2022-09-30A$0.42 B2.08%
2021-09-30A$0.41 B391.78%
2020-09-30A$84.73 M-45.92%
2019-09-30A$0.15 B591.47%
2018-09-30A$22.65 M-23.22%
2017-09-30A$29.51 M-32%
2016-09-30A$43.4 M34.36%
2015-09-30A$32.3 M67.7%
2014-09-30A$19.26 M54.85%
2013-09-30A$12.44 M66.89%
2012-09-30A$7.45 M118.43%
2011-09-30A$3.41 M-23.04%
2010-09-30A$4.43 M35.38%
2009-09-30A$3.27 M-47.61%
2008-09-30A$6.25 M64.63%
2007-09-30A$3.79 M-2.99%
2006-09-30A$3.91 M190.3%
2005-09-30A$1.34 M40.15%
2004-09-30A$0.96 M578.85%
2003-09-30A$0.14 M-95.23%
2002-09-30A$2.96 M8.12%
2001-09-30A$2.74 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$171.42 B 7,070.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
A$5.84 B 144.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.76 B-67.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$5.80 B 142.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
A$62.59 M-97.38%๐Ÿ‡บ๐Ÿ‡ธ USA